Spray coated glass containers with uncoated window and methods of coating the glass containers

Abstract

A spray coating apparatus for coating a portion of a glass object is provided that includes a coating material source; a spray nozzle assembly with a spray nozzle fluidly connected to the coating material source and arranged to direct the coating material in a first direction toward the glass object; and a shadow mask disposed between the glass object and the spray nozzle. The shadow mask includes a masking material at a first masking position in a line of sight between a window portion of the glass object and the spray nozzle. The masking material blocks the coating material from depositing on the window portion of the glass object. The shadow mask also includes a masking material at lateral masking positions on lateral sides of the first masking position to prevent overspray of the coating material from being redirected around the shadow mask and onto the glass object.

Description

Attorney Docket No. SP24-161CONTACTLESS MASK USED IN SPRAY COATING GLASS CONTAINERS AND METHODS OF COATING GLASS CONTAINERSCROSS REFERENCE TO RELATED APPLICATION

[0001] This application claims the benefit of priority under 35 U.S.C. § 119 of U.S. Provisional Application Serial No. 63 / 736,350 filed on December 19, 2024 and U.S. Provisional Application Serial No. 63 / 725,880 filed on November 27, 2024, the content of which are relied upon and incorporated herein by reference in their entirety.BACKGROUNDField

[0002] The present specification generally relates to glass articles and, more specifically, to coating on glass articles such as pharmaceutical packages.Technical Background

[0003] Historically, glass has been used as the preferred material for packaging pharmaceuticals because of its hermeticity, optical clarity, and excellent chemical durability relative to other materials. Some pharmaceutical compositions may be sensitive to ultraviolet light, and may be susceptible to degradation when exposed to ultraviolet light. Some glass compositions have been developed which at least partially block UV light. However, these glass compositions may have inferior properties with respect to, without limitation, glass delamination and / or outer surface coefficient of friction. In addition, these glass compositions or coatings to at least partially block UV light may also block visible light and obscure views of the contents within glass containers, such as pharmaceutical packaging.BRIEF SUMMARY OF SOME EMBODIMENTS

[0004] According to embodiments, a partially coated pharmaceutical package may comprise a glass container comprising a first surface and a second surface opposite the first surface, wherein the first surface is an outer surface of the glass container. The partiallyAttorney Docket No. SP24-161 coated pharmaceutical package may further comprise at least one coated portion comprising a coating positioned over a portion of the first surface of the glass container, wherein the partially coated pharmaceutical package has an average light transmittance in the UVC spectrum of less than 50% through a single wall of the partially coated package in the coated portion, and wherein the partially coated pharmaceutical package has a light transmittance of less than 20% at all wavelengths from 400 nm to 450 nm in the coated portion. The partially coated pharmaceutical package may further comprise at least one window portion which has an average light transmittance in the UVB and UVC spectrum of at least 50% through a single wall of the partially coated package in the window portion.

[0005] According to embodiments, a method of partially coating a glass package with a coating material is provided. The method may include gripping the glass package with a clamping device. The coating material is directed onto an outer surface of the glass package using a spray nozzle. The spray nozzle is arranged and configured to direct the coating material in a first direction toward the glass package. The method includes providing a noncontact spray mask between the glass package and the spray nozzle, wherein the non-contact spray mask is not in physical contact with the glass package. The non-contact spray mask is arranged and configured to block a line of sight from the spray nozzle to a window portion of the glass package where the glass package is not intended to be coated by the coating material, and to have an uninterrupted line of sight to at least a portion of glass package intended to be coated by the coating material. The non-contact spray mask is further arranged and configured to block the coating material from being sprayed to either lateral side of the glass package to prevent droplets of the coating material from landing in the window portion.

[0006] According to embodiments, a non-contact spray mask is provided for selectively applying a coating to a glass package. The spray mask includes a surface configured for blocking a coating material sprayed from a spray nozzle. The spray mask further includes at least one opening configured for allowing an uninterrupted line of sight between a spray nozzle and a portion of the glass package to be coated by the coating material.

[0007] According to one or more embodiments, a coated pharmaceutical package may comprise a glass container comprising a first surface and a second surface opposite the firstAttorney Docket No. SP24-161 surface, wherein the first surface is an outer surface of the glass container, and wherein the glass container in an uncoated state has an average light transmittance in the UVB and UVC spectrum of at least 50% through a single wall of the coated package. The coated pharmaceutical package may further comprise a coating positioned over at least a portion of the first surface of the glass container, wherein the coated pharmaceutical package has an average light transmittance in the UVC spectrum of less than 50% through a single wall of the coated package, and wherein the coated pharmaceutical package has a light transmittance of less than 20% at all wavelengths from 400 nm to 450 nm.

[0008] According to one or more additional embodiments, a coated pharmaceutical package may comprise a glass container comprising a first surface and a second surface opposite the first surface, wherein the first surface is an outer surface of the glass container, and wherein the glass container in an uncoated state has an average light transmittance in the UVB and UVC spectrum of at least 50% through a single wall of the coated package. The coated pharmaceutical package may further comprise a coating positioned over at least a portion of the first surface of the glass container, wherein the coated package has an average light transmittance in the UVC spectrum of less than 50% through a single wall of the coated package, and wherein the coated pharmaceutical package is visibly colorless.

[0009] Additional features and advantages of the coatings that may be used for coating glass articles, coated glass articles, and methods and processes for manufacturing the same will be set forth in the detailed description which follows, and in part will be readily apparent to those skilled in the art from that description or recognized by practicing the embodiments described herein, including the detailed description which follows, the claims, as well as the appended drawings.

[0010] It is to be understood that both the foregoing general description and the following detailed description describe various embodiments and are intended to provide an overview or framework for understanding the nature and character of the claimed subject matter. The accompanying drawings are included to provide a further understanding of the various embodiments, and are incorporated into and constitute a part of this specification. TheAttorney Docket No. SP24-161 drawings illustrate the various embodiments described herein, and together with the description serve to explain the principles and operations of the claimed subject matter.BRIEF DESCRIPTION OF THE DRAWINGS

[0011] FIG. 1 schematically depicts a cross sectional view of a glass container with a coating portion and window portion, according to one or more embodiments shown and described herein;

[0012] FIG. 2 schematically depicts an enlarged cross-sectional view of the glass container of FIG. 1 with a coating, according to one or more embodiments shown and described herein;

[0013] FIG. 3 schematically depicts a testing jig for determining the coefficient of friction between two surfaces, according to one or more embodiments shown and described herein;

[0014] FIG. 3 depicts a scanning electron microscope image of coatings herein, according to one or more embodiments shown and described herein;

[0015] FIG. 4 depicts a scanning electron microscope image of coatings herein, according to one or more embodiments shown and described herein;

[0016] FIG. 5 depicts a light absorbance spectrum of a metal oxide layer or sublayer, according to one or more embodiments shown and described herein; and

[0017] FIG. 6 depicts a light transmission spectrum of an example embodiment, according to one or more embodiments shown and described herein;

[0018] FIG. 7 depicts light transmission data of example embodiments, according to one or more embodiments shown and described herein;

[0019] FIG. 8 depicts light transmission spectra of example embodiments, according to one or more embodiments shown and described herein;

[0020] FIG. 9 depicts light transmission spectra of example embodiments, according to one or more embodiments shown and described herein;Attorney Docket No. SP24-161

[0021] FIG. 10 depicts coefficient of friction data of example embodiments, according to one or more embodiments shown and described herein;

[0022] FIG. 11 depicts light transmission spectra of example embodiments, according to one or more embodiments shown and described herein;

[0023] FIG. 12 depicts light transmission spectra of example embodiments, according to one or more embodiments shown and described herein; and

[0024] FIG. 13 depicts light transmission spectra of example embodiments, according to one or more embodiments shown and described herein.

[0025] Fig. 14 is a photograph of a partially coated vial showing coating defects, according to embodiments.

[0026] Fig. 15 depicts a contactless shadow mask on a coating line, according to embodiments.

[0027] Fig. 16 depicts the transitions between coated and window portions of vials using different masking techniques, according to embodiments.

[0028] Fig. 17 is a graph showing the percentage of area in the window portion covered with droplets after masking, according to embodiments.

[0029] Fig. 18A is a brightfield image of a vial with a window portion between two coated portions, according to embodiments.

[0030] Fig. 18B is a close-up view of the transition region between the window portion and the coated portion in Fig. 18A.

[0031] Fig. 18C is a graph of the percent transmission in the window portion of the vial, according to embodiments.Attorney Docket No. SP24-161DETAILED DESCRIPTION

[0032] Conventional glass pharmaceutical packages that are designed to block ultraviolet (sometimes described herein as “UV”) transmission, such as amber glass containers, generally utilize glass compositions that function to block the UV light. That is the glass itself is responsible for blocking the UV light. Such glasses may contain pigmented materials, such as the case with amber glass compositions that not only appear colored in the visible spectrum, but also block UV light. Such conventional packages do not include coatings applied to the surface of the glass that serve to substantially affect UV transmission.

[0033] Described herein, according to one or more embodiments, are glass containers (such as pharmaceutical packages) that include coatings that block all or some of UV light. The containers, absent the coating, may not substantially block UV light to a degree desired. Such coatings allow for glass compositions to be utilized that do not block all UV light desired to be blocked. In some embodiments, the coatings may generally block UV light while allowing for the transmission of visible light. Such embodiments may be advantageous, in one or more embodiments, because “clear” glasses with improved properties may be utilized as opposed to traditional amber glass compositions and / or the coated glass containers may appear clear while being functional to block UV light. In additional embodiments, the coatings (as well as the coated articles) may appear colored and provide UV blocking functionality. These embodiments may be beneficial because “clear” glass containers may be utilized rather than colored glass containers, where colored glasses may be prone to glass degradation and / or may be more costly to produce in bulk. For example, switching between colored and non-colored glass in a single manufacturing set-up may be costly since much glass is wasted transitioning between the desired colored and non-colored glass compositions. The coating may additionally provide desirable properties such as reduced coefficient of friction as compared to the glass body surface, and may be thermally stable through depyrogenation, a heating process commonly employed in pharmaceutical filling.

[0034] Reference will now be made in detail to various embodiments of coatings, glass articles with coatings, and methods for producing the same, examples of which are schematically depicted in the figures. Such coated glass articles may be glass containersAttorney Docket No. SP24-161 suitable for use in various packaging applications including, without limitation, as pharmaceutical packages. It should be understood that coated glass articles may refer to coated pharmaceutical packages as described in this disclosure. In one or more embodiments, the coatings and / or the coated pharmaceutical packages at least partially block the transmission of ultraviolet light into the container. However, the glass composition and / or the uncoated glass container may generally not have UV blocking properties that appreciably contribute to the UV blocking of the coated glass article. These pharmaceutical packages may or may not contain a pharmaceutical composition.

[0035] Various embodiments of the coatings, glass articles with coatings, and methods for forming the same will be described in further detail herein with specific reference to the appended drawings. While embodiments of the coatings described herein are applied to the outer surface of a glass container, it should be understood that the coatings described may be used as a coating on a wide variety of materials, including non-glass materials and on substrates other than containers including, without limitation, glass display panels and the like.

[0036] Generally, a coating may be applied to a surface of a glass article, such as a container that may be used as a pharmaceutical package. The coating may provide advantageous properties to the coated glass article such as UV light blocking, a reduced coefficient of friction, and increased damage resistance. The reduced coefficient of friction may impart improved strength and durability to the glass article by mitigating frictive damage to the glass. Further, the coating may maintain the aforementioned improved strength and durability characteristics following exposure to elevated temperatures and other conditions, such as those experienced during packaging and pre-packaging steps utilized in packaging pharmaceuticals, such as, for example, depyrogenation, lyophilization, autoclaving and the like. Accordingly, the coatings and glass articles with the coating may be thermally stable at conditions such as those utilized in depyrogenation.

[0037] FIG. 1 schematically depicts a cross section of a coated glass article, specifically a partially coated glass container 100. The partially coated glass container 100 comprises a glass body 102 and a coating 120. The glass body 102 has a glass container wall 104Attorney Docket No. SP24-161 extending between an exterior surface 108 (i.e., a first surface) and an interior surface 110 (i.e., a second surface). The interior surface 110 of the glass container wall 104 defines an interior volume 106 of the partially coated glass container 100. A coating 120 is positioned on at least one coated portion 126 of the exterior surface 108 of the glass body 102. As used herein, a coating may be “positioned on” the exterior surface 108 while not in direct contact with the exterior surface 108, such as if an intermediate layer is present between the exterior surface 108 and a coating positioned over the exterior surface 108. In embodiments, the coated glass container 100 is a partially coated glass container and may have a window portion 128 in which the coating 120 is not present. In some embodiments, the coating 120 may be positioned on substantially the entire exterior surface 108 of the glass body 102. In some embodiments, such as depicted in FIG. 1, the coating 120 may be bonded to the glass body 102 at the exterior surface 108. In the embodiment of FIG. 1, the coating 120 has an outer surface 122 and a glass body contacting surface 124 at the interface of the glass body 102 and the coating 120.

[0038] In one embodiment, the partially coated glass container 100 is a pharmaceutical package. For example, the glass body 102 may be in the shape of a vial, ampoule, ampul, bottle, flask, phial, beaker, bucket, carafe, vat, syringe body, or the like. The coated glass container 100 may be used for containing any composition, and in one embodiment, may be used for containing a pharmaceutical composition. A pharmaceutical composition may include any chemical substance intended for use in the medical diagnosis, cure, treatment, or prevention of disease. Examples of pharmaceutical compositions include, but are not limited to, medicines, drugs, medications, medicaments, remedies, and the like. The pharmaceutical composition may be in the form of a liquid, solid, gel, suspension, powder, or the like.

[0039] Now referring to FIGS. 1 and 2, in one embodiment, the coating 120 comprises a single-layered structure. For example, the coating 120 may have a substantially homogenous composition comprising a polymer. If two or more components are included in the coating 120, the coating 120 may be mixed but not fully homogenous. For example, in one or more embodiments, one or more chemical constituents of the mixture may congregate at an interface of the coating 120 (e.g., the interface with the glass body 102 or the outer surfaceAttorney Docket No. SP24-161122). In such an embodiment, the local concentration of a chemical constituent may differ over different areas of the coating 120. However, it should be understood that the term “mixed” as used herein refers to layers that have at least some dispersion of at least two chemical components, and includes layers that are not fully homogenous. Generally, a mixed layer is deposited as a mixture of two or more chemical constituents contained in a coating mixture. However, according to additional embodiments, the coating 120 may comprise two or more distinct layers. According to additional embodiments, the coating 120 may be multilayered, having two or more distinct layers. For example, the coating 120 may include a coupling agent layer contacting the exterior surface 108 and a polymer layer over the coupling agent layer.

[0040] The transparency of the electromagnetic spectrum (z.e., light) through articles may be assessed by measuring the light transmission using a spectrophotometer. Measurements may be made through uncoated pharmaceutical containers, coated containers, and through planar glass sheets that are coated or uncoated.

[0041] In one or more embodiments, the glass body 102 may be transmissive of UV light (at least as compared with commercially available amber vials). The coating 120 may provide the majority of the UV blocking. Additionally, while the coating may provide UV blocking, in one or more embodiments, the coating may be transmissible to visible light such that it is not colored. In some embodiments, the coated glass container 100 may be transmissible to visible light but may block UV light. In other embodiments, the coated glass container may block some visible light (i.e., be colored) and may additionally block UV light. These light transmission properties are described quantitatively herein. As described herein, it should be appreciated that when UV light is “blocked” all or some UV light is blocked, and even in glass compositions that are said to not block UV light, some small amount of UV radiation may not be transmitted in all wavelengths. In embodiments of the partially coated glass container 100, it should be understood that the coating, which may block some or more than 50% of visible light, is disposed on the at least one coated portion 126, so the at least one coated portion may provide UV blocking, while the coating 120 is absent from the windowAttorney Docket No. SP24-161 portion 128 so that the window portion 128 is transparent or blocks less than 50% of visible light.

[0042] As described herein, UV light (sometimes called light in the UV spectrum) refers to light having a wavelength of from 200 to 400 nm. UV light may include UVA light, UVB light, and UVC light. UVA light, as descried herein, refers to light with a wavelength of from 200 to 290 nm. UVB light, as descried herein, refers to light with a wavelength of from 290 to 320 nm. UVC light, as descried herein, refers to light with a wavelength of from 320 to 400 nm. Visible light, as described herein, refers to light having wavelength of from 400 to 700 nm. As described herein, “average light transmittance” over a wavelength range refers to the average transmittance as could be determined by a spectrophotometer over a particular wavelength range. The “maximum light transmittance” over a wavelength range refers to the maximum transmittance at a single wavelength in the wavelength range.

[0043] Where light transmittance is described with respect to the glass composition, the glass container, or the glass wall, in an “uncoated state” a measurement may be attained by testing an uncoated container or glass substrate. Unless described otherwise herein, light transmittance is measured through a single wall of the coated glass container. Uncoated state refers to the glass article without a coating.

[0044] It should be understood that the described transmittances disclosed herein with respect to a coated glass container 100, a glass body 102 (uncoated), or a coating 120 may be measured through a coated or uncoated container (passing through two walls) or through a single wall of a container (coated or uncoated) or through a planar sheet of glass having a thickness similar to a pharmaceutical package (coated or uncoated). The light transmissibility of a coating 120 may be determined by measuring the light transmittance through the substrate material (e.g., the glass body 120) and the coated glass container 100, separately, and determining the difference between the two measured specimens. It should be understood that the described transmittances disclosed herein with respect to the window portion 128 of the glass container 100 may be measured through a coated or uncoated container (passing through two walls) or through a single wall of a container (coated or uncoated) or through a planar sheet of glass having a thickness similar to a pharmaceutical package (coated orAttorney Docket No. SP24-161 uncoated). The window portion 128 may be coated or coated, so long as the coating is not the same UV-blocking coating of the coating portion, is substantially transparent to visible light, and / or is more transparent to visible light than the coated portion 128 so that a user can more accurately observe the contents of the glass container 100 through the window portion.

[0045] According to one or more embodiments, the at least one coated portion 126 of the coated glass container 100 may have an average light transmittance in the UV spectrum of less than or equal to 95%, less than or equal to 90%, less than or equal to 85%, less than or equal to 80%, less than or equal to 75%, less than or equal to 70%, less than or equal to 65%, less than or equal to 60%, less than or equal to 55%, less than or equal to 50%, less than or equal to 45%, less than or equal to 40%, less than or equal to 35%, less than or equal to 30%, less than or equal to 25%, less than or equal to 20%, less than or equal to 15%, less than or equal to 10%, less than or equal to 7.5%, less than or equal to 5%, less than or equal to 2.5%, or even less than or equal to 1%.

[0046] According to one or more embodiments, the at least one coated portion 126 of the coated glass container 100 may have an average light transmittance in the UVA spectrum of less than or equal to 95%, less than or equal to 90%, less than or equal to 85%, less than or equal to 80%, less than or equal to 75%, less than or equal to 70%, less than or equal to 65%, less than or equal to 60%, less than or equal to 55%, less than or equal to 50%, less than or equal to 45%, less than or equal to 40%, less than or equal to 35%, less than or equal to 30%, less than or equal to 25%, less than or equal to 20%, less than or equal to 15%, less than or equal to 10%, less than or equal to 7.5%, less than or equal to 5%, less than or equal to 2.5%, or even less than or equal to 1%.

[0047] According to one or more embodiments, the at least one coated portion 126 of the coated glass container 100 may have an average light transmittance in the UVB spectrum of less than or equal to 95%, less than or equal to 90%, less than or equal to 85%, less than or equal to 80%, less than or equal to 75%, less than or equal to 70%, less than or equal to 65%, less than or equal to 60%, less than or equal to 55%, less than or equal to 50%, less than or equal to 45%, less than or equal to 40%, less than or equal to 35%, less than or equal to 30%, less than or equal to 25%, less than or equal to 20%, less than or equal to 15%, lessAttorney Docket No. SP24-161 than or equal to 10%, less than or equal to 7.5%, less than or equal to 5%, less than or equal to 2.5%, or even less than or equal to 1%.

[0048] According to one or more embodiments, the at least one coated portion 126 of the coated glass container 100 may have an average light transmittance in the UVC spectrum of less than or equal to 95%, less than or equal to 90%, less than or equal to 85%, less than or equal to 80%, less than or equal to 75%, less than or equal to 70%, less than or equal to 65%, less than or equal to 60%, less than or equal to 55%, less than or equal to 50%, less than or equal to 45%, less than or equal to 40%, less than or equal to 35%, less than or equal to 30%, less than or equal to 25%, less than or equal to 20%, less than or equal to 15%, less than or equal to 10%, less than or equal to 7.5%, less than or equal to 5%, less than or equal to 2.5%, or even less than or equal to 1%.

[0049] According to one or more embodiments, the at least one coated portion 126 of the coated glass container 100 may have a maximum light transmittance in the UV spectrum of less than or equal to 95%, less than or equal to 90%, less than or equal to 85%, less than or equal to 80%, less than or equal to 75%, less than or equal to 70%, less than or equal to 65%, less than or equal to 60%, less than or equal to 55%, less than or equal to 50%, less than or equal to 45%, less than or equal to 40%, less than or equal to 35%, less than or equal to 30%, less than or equal to 25%, less than or equal to 20%, less than or equal to 15%, less than or equal to 10%, less than or equal to 7.5%, less than or equal to 5%, less than or equal to 2.5%, or even less than or equal to 1%.

[0050] According to one or more embodiments, the at least one coated portion 126 of the coated glass container 100 may have a maximum light transmittance in the UVA spectrum of less than or equal to 95%, less than or equal to 90%, less than or equal to 85%, less than or equal to 80%, less than or equal to 75%, less than or equal to 70%, less than or equal to 65%, less than or equal to 60%, less than or equal to 55%, less than or equal to 50%, less than or equal to 45%, less than or equal to 40%, less than or equal to 35%, less than or equal to 30%, less than or equal to 25%, less than or equal to 20%, less than or equal to 15%, less than or equal to 10%, less than or equal to 7.5%, less than or equal to 5%, less than or equal to 2.5%, or even less than or equal to 1%.Attorney Docket No. SP24-161

[0051] According to one or more embodiments, the at least one coated portion 126 of the coated glass container 100 may have a maximum light transmittance in the UVB spectrum of less than or equal to 95%, less than or equal to 90%, less than or equal to 85%, less than or equal to 80%, less than or equal to 75%, less than or equal to 70%, less than or equal to 65%, less than or equal to 60%, less than or equal to 55%, less than or equal to 50%, less than or equal to 45%, less than or equal to 40%, less than or equal to 35%, less than or equal to 30%, less than or equal to 25%, less than or equal to 20%, less than or equal to 15%, less than or equal to 10%, less than or equal to 7.5%, less than or equal to 5%, less than or equal to 2.5%, or even less than or equal to 1%.

[0052] According to one or more embodiments, the at least one coated portion 126 of the coated glass container 100 may have a maximum light transmittance in the UVC spectrum of less than or equal to 95%, less than or equal to 90%, less than or equal to 85%, less than or equal to 80%, less than or equal to 75%, less than or equal to 70%, less than or equal to 65%, less than or equal to 60%, less than or equal to 55%, less than or equal to 50%, less than or equal to 45%, less than or equal to 40%, less than or equal to 35%, less than or equal to 30%, less than or equal to 25%, less than or equal to 20%, less than or equal to 15%, less than or equal to 10%, less than or equal to 7.5%, less than or equal to 5%, less than or equal to 2.5%, or even less than or equal to 1%.

[0053] According to one or more embodiments, the glass body 102 (uncoated) and / or the window portion 128 of the glass container 110 may have an average light transmittance in the UV spectrum of at least 5%, at least 10%, at least 15%, at least 20%, at least 25%, at least 30%, at least 35%, at least 40%, at least 45%, at least 50%, at least 55%, at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, or even at least 99%.

[0054] According to one or more embodiments, the glass body 102 (uncoated) and / or the window portion 128 of the glass container 110 may have an average light transmittance in the UVA spectrum of at least 5%, at least 10%, at least 15%, at least 20%, at least 25%, at least 30%, at least 35%, at least 40%, at least 45%, at least 50%, at least 55%, at least 60%, at leastAttorney Docket No. SP24-16165%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, or even at least 99%.

[0055] According to one or more embodiments, the glass body 102 (uncoated) and / or the window portion 128 of the glass container 110 may have an average light transmittance in the UVB spectrum of at least 5%, at least 10%, at least 15%, at least 20%, at least 25%, at least 30%, at least 35%, at least 40%, at least 45%, at least 50%, at least 55%, at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, or even at least 99%.

[0056] According to one or more embodiments, the glass body 102 (uncoated) and / or the window portion 128 of the glass container 110 may have an average light transmittance in the UVC spectrum of at least 5%, at least 10%, at least 15%, at least 20%, at least 25%, at least 30%, at least 35%, at least 40%, at least 45%, at least 50%, at least 55%, at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, or even at least 99%.

[0057] According to one or more embodiments, the glass body 102 (uncoated) and / or the window portion 128 of the glass container 110 may have a minimum light transmittance in the UV spectrum of at least 5%, at least 10%, at least 15%, at least 20%, at least 25%, at least 30%, at least 35%, at least 40%, at least 45%, at least 50%, at least 55%, at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, or even at least 99%.

[0058] According to one or more embodiments, the glass body 102 (uncoated) and / or the window portion 128 of the glass container 110 may have a minimum light transmittance in the UVA spectrum of at least 5%, at least 10%, at least 15%, at least 20%, at least 25%, at least 30%, at least 35%, at least 40%, at least 45%, at least 50%, at least 55%, at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, or even at least 99%.

[0059] According to one or more embodiments, the glass body 102 (uncoated) and / or the window portion 128 of the glass container 110 may have a minimum light transmittance inAttorney Docket No. SP24-161 the UVB spectrum of at least 5%, at least 10%, at least 15%, at least 20%, at least 25%, at least 30%, at least 35%, at least 40%, at least 45%, at least 50%, at least 55%, at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, or even at least 99%.

[0060] According to one or more embodiments, the glass body 102 (uncoated) and / or the window portion 128 of the glass container 110 may have a minimum light transmittance in the UVC spectrum of at least 5%, at least 10%, at least 15%, at least 20%, at least 25%, at least 30%, at least 35%, at least 40%, at least 45%, at least 50%, at least 55%, at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, or even at least 99%.

[0061] According to one or more embodiments, the coating 120 may have an average light transmittance in the UV spectrum of less than or equal to 50%, less than or equal to 45%, less than or equal to 40%, less than or equal to 35%, less than or equal to 30%, less than or equal to 25%, less than or equal to 20%, less than or equal to 15%, less than or equal to 10%, less than or equal to 7.5%, less than or equal to 5%, less than or equal to 2.5%, or even less than or equal to 1%.

[0062] According to one or more embodiments, the coating 120 may have an average light transmittance in the UV spectrum of less than or equal to 95%, less than or equal to 90%, less than or equal to 85%, less than or equal to 80%, less than or equal to 75%, less than or equal to 70%, less than or equal to 65%, less than or equal to 60%, less than or equal to 55%, less than or equal to 50%, less than or equal to 45%, less than or equal to 40%, less than or equal to 35%, less than or equal to 30%, less than or equal to 25%, less than or equal to 20%, less than or equal to 15%, less than or equal to 10%, less than or equal to 7.5%, less than or equal to 5%, less than or equal to 2.5%, or even less than or equal to 1%.

[0063] According to one or more embodiments, the coating 120 may have an average light transmittance in the UVA spectrum of less than or equal to 95%, less than or equal to 90%, less than or equal to 85%, less than or equal to 80%, less than or equal to 75%, less than or equal to 70%, less than or equal to 65%, less than or equal to 60%, less than or equal toAttorney Docket No. SP24-16155%, less than or equal to 50%, less than or equal to 45%, less than or equal to 40%, less than or equal to 35%, less than or equal to 30%, less than or equal to 25%, less than or equal to 20%, less than or equal to 15%, less than or equal to 10%, less than or equal to 7.5%, less than or equal to 5%, less than or equal to 2.5%, or even less than or equal to 1%.

[0064] According to one or more embodiments, the coating 120 may have an average light transmittance in the UVB spectrum of less than or equal to 95%, less than or equal to 90%, less than or equal to 85%, less than or equal to 80%, less than or equal to 75%, less than or equal to 70%, less than or equal to 65%, less than or equal to 60%, less than or equal to 55%, less than or equal to 50%, less than or equal to 45%, less than or equal to 40%, less than or equal to 35%, less than or equal to 30%, less than or equal to 25%, less than or equal to 20%, less than or equal to 15%, less than or equal to 10%, less than or equal to 7.5%, less than or equal to 5%, less than or equal to 2.5%, or even less than or equal to 1%.

[0065] According to one or more embodiments, the coating 120 may have an average light transmittance in the UVC spectrum of less than or equal to 95%, less than or equal to 90%, less than or equal to 85%, less than or equal to 80%, less than or equal to 75%, less than or equal to 70%, less than or equal to 65%, less than or equal to 60%, less than or equal to 55%, less than or equal to 50%, less than or equal to 45%, less than or equal to 40%, less than or equal to 35%, less than or equal to 30%, less than or equal to 25%, less than or equal to 20%, less than or equal to 15%, less than or equal to 10%, less than or equal to 7.5%, less than or equal to 5%, less than or equal to 2.5%, or even less than or equal to 1%.

[0066] According to one or more embodiments, the coating 120 may have a maximum light transmittance in the UV spectrum of less than or equal to 95%, less than or equal to 90%, less than or equal to 85%, less than or equal to 80%, less than or equal to 75%, less than or equal to 70%, less than or equal to 65%, less than or equal to 60%, less than or equal to 55%, less than or equal to 50%, less than or equal to 45%, less than or equal to 40%, less than or equal to 35%, less than or equal to 30%, less than or equal to 25%, less than or equal to 20%, less than or equal to 15%, less than or equal to 10%, less than or equal to 7.5%, less than or equal to 5%, less than or equal to 2.5%, or even less than or equal to 1%.Attorney Docket No. SP24-161

[0067] According to one or more embodiments, the coating 120 may have a maximum light transmittance in the UVA spectrum of less than or equal to 95%, less than or equal to 90%, less than or equal to 85%, less than or equal to 80%, less than or equal to 75%, less than or equal to 70%, less than or equal to 65%, less than or equal to 60%, less than or equal to 55%, less than or equal to 50%, less than or equal to 45%, less than or equal to 40%, less than or equal to 35%, less than or equal to 30%, less than or equal to 25%, less than or equal to 20%, less than or equal to 15%, less than or equal to 10%, less than or equal to 7.5%, less than or equal to 5%, less than or equal to 2.5%, or even less than or equal to 1%.

[0068] According to one or more embodiments, the coating 120 may have a maximum light transmittance in the UVB spectrum of less than or equal to 95%, less than or equal to 90%, less than or equal to 85%, less than or equal to 80%, less than or equal to 75%, less than or equal to 70%, less than or equal to 65%, less than or equal to 60%, less than or equal to 55%, less than or equal to 50%, less than or equal to 45%, less than or equal to 40%, less than or equal to 35%, less than or equal to 30%, less than or equal to 25%, less than or equal to 20%, less than or equal to 15%, less than or equal to 10%, less than or equal to 7.5%, less than or equal to 5%, less than or equal to 2.5%, or even less than or equal to 1%.

[0069] According to one or more embodiments, the coating 120 may have a maximum light transmittance in the UVC spectrum of less than or equal to 95%, less than or equal to 90%, less than or equal to 85%, less than or equal to 80%, less than or equal to 75%, less than or equal to 70%, less than or equal to 65%, less than or equal to 60%, less than or equal to 55%, less than or equal to 50%, less than or equal to 45%, less than or equal to 40%, less than or equal to 35%, less than or equal to 30%, less than or equal to 25%, less than or equal to 20%, less than or equal to 15%, less than or equal to 10%, less than or equal to 7.5%, less than or equal to 5%, less than or equal to 2.5%, or even less than or equal to 1%.

[0070] In one or more embodiments, the partially coated glass container 100 may meet the “Spectral Transmission for Colored Glass Containers” requirements of USP <660>.Generally, such standards are defined in USP <660> and utilize a UV-Vis spectrographic analysis whereby the wavelengths of from 290-450 nm are measured. In some embodiments, the partially coated glass container 100 may be perceived as colorless and transparent to theAttorney Docket No. SP24-161 naked human eye when viewed at any angle. In some other embodiments, the coating 120 may have a perceptible tint, such as when the coating 120 comprises a polymer which is colored. In one or more embodiments, the light transmission through the partially coated glass container 100 is greater than or equal to about 55%, about 60%, about 65%, about 70%, about 75%, about 80%, or even about 90% of a light transmission through an uncoated glass container for wavelengths from about 400 nm to about 700 nm. However, in additional embodiments, the coated portion 126 of the partially coated glass container 100 may be colored, such as amber, brown, or yellow in color.

[0071] In one or more embodiments, the coated glass container 100 may have protection from radiation of 400-450 nm wavelength, which is consistent with the standards of USP <660> described herein. For example, the coated portion 126 of the partially coated glass container 100 may have a light transmittance of less than 20% at all wavelengths from 400 nm to 450 nm. In additional embodiments, the coated glass container 100 may have a light transmittance of less than 15%, less than 10%, or even less than 5%, at all wavelengths from 400 nm to 450 nm. In such embodiments, where the coating does not significantly block higher wavelength visible radiation, the coated glass container 100 may have an amber or brown perceivable color.

[0072] In one or more embodiments, the coated portion 126 of the partially coated glass container 100 may have an average light transmittance in the visible spectrum of at least 5%, at least 10%, at least 15%, at least 20%, at least 25%, at least 30%, at least 35%, at least 40%, at least 45%, at least 50%, at least 55%, at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, or even at least 99%. In additional embodiments, the glass body 102 may have such an average light transmittance in spectrums of from 400-450 nm, from 450-500 nm, from 500-550 nm, from 550-600 nm, from 600-650 nm, from 650-700 nm, or in any combination of these ranges.

[0073] In one or more embodiments, the coated portion 126 of the coated glass article 100 may have a minimum light transmittance in the visible spectrum of at least 5%, at least 10%, at least 15%, at least 20%, at least 25%, at least 30%, at least 35%, at least 40%, at least 45%, at least 50%, at least 55%, at least 60%, at least 65%, at least 70%, at least 75%, at least 80%,Attorney Docket No. SP24-161 at least 85%, at least 90%, at least 95%, or even at least 99%. In additional embodiments, the glass body 102 may have such a minimum light transmittance in spectrums of the ranges described for wavelength ranges of from 400-450 nm, from 450-500 nm, from 500-550 nm, from 550-600 nm, from 600-650 nm, from 650-700 nm, or in any combination of these ranges.

[0074] As described herein, a light transmission can be measured before an environmental treatment, such as a thermal treatment described herein, or after an environmental treatment. For example, following a heat treatment of about 250 °C, about 260 °C, about 270 °C, about 280 °C, about 290 °C, about 300 °C, about 310 °C, about 320 °C, about 330 °C, about 340 °C, about 350 °C, about 360 °C, about 370 °C, about 380 °C, about 390 °C, or about 400 °C, for a period of time of 30 minutes, or after exposure to lyophilization conditions, or after exposure to autoclave conditions, the disclosed optical transmission properties may be observed.

[0075] In one or more embodiments, the glass body 102 (uncoated) and / or the window portion 128 is visibly colorless, or is at least not colored like a traditional amber colored glass. For example, the glass body 102 in an uncoated state and / or the window portion 128 may be perceived as colorless and transparent to the naked human eye when viewed at any angle. As described herein, visibly colorless refers to no perceivable color by the average human eye. In one or more embodiments, the light transmission through the glass body 102 in an uncoated state and / or the window portion 128 may be greater than or equal to about 55%, about 60%, about 65%, about 70%, about 75%, about 80%, or even about 90% for all wavelengths in the visible spectrum. For reference, clear aluminosilicate or borosilicate glass has light transmission of about 87-88% for all wavelengths in the visible spectrum.

[0076] The coating 102 may possess a wide variety of compositions and structures. In some embodiments, coatings may be applied which provide UV blocking properties. In one or more embodiments, the coating may comprise a thickness sufficient to reduce ultraviolet light transmission. In one or more embodiments, the thickness of the coating sufficient to reduce ultraviolet light may be at least 10 nm. For example, the thickness of the coating may be at least 10 nm, at least, 20 nm, at least 30 nm, at least 40 nm, at least 50 nm, at least 60Attorney Docket No. SP24-161 nm, at least 70 nm, at least 80 nm, at least 90 nm, at least 100 nm, at least 200 nm, at least 300 nm, at least 400 nm, at least 500 nm, at least 600 nm, at least 700 nm, at least 800 nm, at least 900 nm, or even at least 1000 nm, at least 2 microns, at least 3 microns, at least 4 microns, at least 5 microns, at least 6 microns, at least 7 microns, at least 8 microns, at least 9 microns, at least 10 microns, at least 15 microns, at least 20 microns, or even at least 25 microns.

[0077] In one or more embodiments, the coating may comprise one or more polymers. In one or more embodiments, the one or more polymers may exhibit color detectable by the human eye when deposited at a thickness sufficient to reduce ultraviolet light transmission. In one or more embodiments the color may be a warm color. For example the coating may exhibit a red, yellow, orange, or amber color visible to the human eye.

[0078] In one or more embodiments the one or more polymers may provide a coating that is clear. In one or more embodiments, the coating may possess a clarity sufficient to allow for the automated visual inspection of the contents of a vial comprising the coating. The coating may also possess a clarity sufficient to allow for the manual inspection of the contents of the container, such as manual inspection by a medical professional or end point user. This may be particularly important for the detection of glass delamination within containers.

[0079] In one or more embodiments, the coating may be a visibly colored, thermally stable coating comprising a polymer such as a polyimide, and sometimes a coupling agent such as a silane or metal oxide. In some embodiments, the polymers and / or coupling agents may include a metal, such as silver, copper, iron, or combinations of these, that acts as a pigment and protects against at least UV light and produces the colored appearance. Coating that include copper, iron, and / or silver may have an amber or brown appearance, which may be needed to qualify under USP <660>. Examples of suitable coating systems that include polymers and / or coupling agents, into which the silver, copper, or iron may be incorporated, include those of U.S. Patent No. 9,763,852 entitled “Glass Articles with Low-Friction Coatings,” U.S. Patent Application Publication No. US 2017 / 0121058 Al entitled “Glass Articles With Mixed Polymer and Metal Oxide Coatings,” and U.S. Patent Application Publication No. US 2017 / 0088459 entitled “Halogenated Polyimide Siloxane ChemicalAttorney Docket No. SP24-161Compositions and Glass Articles with Halogenated Polyimide Siloxane Low-Friction Coatings,” the contents of which are incorporated by reference herein. As described herein, the metals that promote UV protection and visibly color the coatings may be incorporated into a polymer layer, a coupling agent layer, or a coating having a mixed coupling agent and polymer layer.

[0080] According to some embodiments, the coating material that is applied to the container, prior to any curing step, may include a polyimide in which colloidal metal particles are present. The colloidal metal particles may be suspended in the polyimide or polyamic acid solution or can be prepared in-situ inside the polymer layer by reduction of metal ions. In such embodiments, the coating may include a reducing agent. Contemplated metal ions are selected from silver ions, copper ions and iron ions. In the case of the in-situ reduction process, soluble metal ions are dissolved in the polyimide or polyamic acid solution in the presence of a reducing agent. This reducing agent can be omitted if the reduction of the metal ions is performed in a reducing atmosphere but addition of reducing agent is sometimes desired. For example, the addition of a reducing agent may be desired as the reduction can be done in a normal atmosphere such as air.

[0081] In embodiments described herein, the metal ions can be used in the form of inorganic salts such as nitrate salt, for example, or in the form of organic salts such as acetates. Silver trifuoroacetate and silver trifluoroacetylacetonate are particularly contemplated. However, other materials that include silver, copper, or iron may be suitable.

[0082] Examples of reducing agents include, without limitation, aminosilane such as N-[3- (Trimethoxysilyl)propyl] ethylenediamine, other aminosilane such aminopropyl tri ethoxysilane, aminopropyl trimethoxysilane, Bis[3-(trimethoxysilyl)propyl]amine, bis[3- (trimethoxysilyl)propyl]ethylenediamine, aminopropylsilsesquioxane, N-(2-Aminoethyl-3- aminopropyl)trimethoxysilane the list being not limitative. In some embodiments, the reducing agent may be a silane. In such embodiments, the reducing agent may act as a coupling agent in the coating, which may improve the adhesion of the polymer fdm to the glass.Attorney Docket No. SP24-161

[0083] In some embodiments, the coating may comprise the polymer that includes the copper, iron, or silver, in a polymer layer, where a coupling agent layer is present between the glass surface and the polymer layer. The coupling agent layer may include aminosilane such as aminopropyl silsequi oxane. In additional embodiments, the coupling agent material may be mixed in to the polymer along with the silver, copper, or iron.

[0084] In additional embodiments, the coating includes a coupling agent layer that includes one or more of silver, copper, or iron, and a polymer layer over the coupling agent layer. In such embodiments, the coupling agent layer may provide UV protection while the polymer layer may provide good coefficient of friction properties and good thermal properties. For example, the polymer layer may comprise a polyimide.

[0085] The UV-blocking coupling agent layer can be prepared by dispersing metal nanoparticles in a silane solution, for example, or can be made by forming the nanoparticle by in-situ reduction of metal ions. In the latter case, the metal ions may be dissolved in a solution containing the adhesion promoter, for example a silane, and at least one reducing agent. In some embodiments the reducing agent is coupling agent, such as a silane, that promotes adhesion. Such coupling agents acting as reducing agents can be selected, without limitation, among the aminosilanes such as N-[3-(Trimethoxysilyl)propyl]ethylenediamine, gamma-aminopropyl triethoxysilane, gamma-aminopropyl trimethoxysilane, bis[3- (trimethoxysilyl)propyl]amine, and bis[3 - (trimethoxysilyl)propyl]ethylenediamine, aminopropylsilsesquioxane .

[0086] According to additional embodiments, the coating may include a polyimide, one or more of silver, copper, or iron, as well as other metal oxides such as alumina, titania, or zirconia. For example, embodiments of coatings that include polyimide and one or more of alumina, titania, or zirconia are disclosed in U.S. Patent Application Publication No. US 2017 / 0121058 Al entitled “Glass Articles with Mixed Polymer and Metal Oxide Coatings.” It should be appreciated that other metal oxides may be utilized besides alumina, titania, and zirconia, which may reduce some UV transmission but do not generally affect visible color of the coating.Attorney Docket No. SP24-161

[0087] In one or more further embodiments, the one or more polymer may comprise a polyimide or other thermally stable polymer that blocks UV radiation without the use of pigmenting metals such as silver, copper, or iron. For example, the polymer may comprise PMDA-ODA polyimide.

[0088] In one or more embodiments the coating may comprise a Bragg mirror. As described herein, a “Bragg mirror” is a layered material that causes the reflection of oncoming light using alternating layers of high and low refractive index material. In one or more embodiments, the Bragg mirror may comprise at least one layer of high refractive index material and at least one layer of low refractive index material. The difference in refractive index between the high refractive index material and the low refractive index material may be at least 0.5. For example, the difference in refractive index between the high refractive index material and the low refractive index material may be at least 0.5, at least 0.6, at least 0.7, at least 0.8, at least 0.9 or even at least 1.0.

[0089] In one or more embodiments, the high refractive index layer may comprise any material with a refractive index that is greater than the refractive index of the low refractive index material by at least 0.5. In one or more embodiments, the high refractive index material may comprise a metal oxide. For example, the high refractive index layer may comprise titania (TiCF). zirconia (ZrCF). or alumina (AIO2). In one or more embodiments, the high refractive index layer may comprise TiCF. Examples of layers that include titania, zirconia, or alumina in a polyimide matrix are described in U.S. Patent Application Publication No. US 2017 / 0121058 entitled “Glass Articles with Mixed Polymer and Metal Oxide Coatings.”

[0090] In one or more embodiments, the low refractive index layer may comprise a material with a refractive index that is less than the refractive index of the high refractive index material by at least 0.5. In one or more embodiments, the low refractive index material may comprise or consist of polyimide that is visibly colorless. In additional embodiments, the low refractive index material may comprise a fluorinated compound. In one or more embodiments, the low refractive index material may comprise a silica compound. For example, the low refractive index material may comprise SiCUAttorney Docket No. SP24-161

[0091] In one or more embodiments, the Bragg mirror may comprise alternating layers. The alternating layers may be high refractive index layers and low refractive index layers. In one or more embodiments adjacent layers of the Bragg mirror may have a difference in refractive index of at least 0.5. For example, the coating may comprise a first high refractive index layer, a first low refractive index layer, and a second high refractive index layer, where the first low refractive index layer is positioned between the first and second high refractive index layers.

[0092] In one or more embodiments, the alternating high and low refractive index layers of the Bragg mirror may reflect ultraviolet light. Without wishing to be bound by theory, each layer boundary may cause a partial reflection of waves within a range of wavelengths. In one or more embodiments, the partial wave reflections may create constructive interference to enhance the reflection of light in one or more wavelengths. In one or more embodiments, the thickness of the alternating high and low refractive index layers may be optimized to enhance the reflection of one or more desired wavelengths. In one or more embodiments, the range of wavelengths reflected by the Bragg mirror may include wavelengths comprising ultraviolet light.

[0093] In one or more embodiments, the coating may comprise a high pass filter. As described herein, a “high pass filter” may be a material that transmits light comprising longer wavelengths than a certain cutoff wavelength. In one or more embodiments, at least one the high refractive index layer and at least one low refractive index layer may be positioned to form a high pass filter. In one or more embodiments, ultraviolet light may comprise wavelengths below the cutoff wavelength of the high pass filter. In one or more embodiments, the high pass filter may transmit visible light and reduce the transmission of ultraviolet light through the coating. For example, the cutoff wavelength may be 400 nm, which may allow the transmission of visible light but prevent the transmission of ultraviolet light.

[0094] According to one or more embodiments, the coating may include a mixed layer of polyimide and one or more of titania, zirconium, or aluminum, as described herein. Over this layer may be positioned a layer of polyimide that does not include substantial amounts ofAttorney Docket No. SP24-161 metal oxides (less than 1 wt.%, or even 0 wt.%). In such embodiments, a Bragg mirror and / or high pass filter functionality may be formed.

[0095] In one or more embodiments, the high pass filter may be a Fabry Perot cavity. As described herein, a “Fabry Perot cavity” is a structure that may comprise two parallel reflecting surfaces and may prevent the transmission of light having wavelengths that are not in resonance with the Fabry Perot cavity. In one or more embodiments, a Fabry Perot cavity may be formed from at least one high refractive index layer, at least one absorbing layer, and at least one low refractive index layer. For example, the Fabry Perot cavity may comprise a high refractive index layer and a low refractive index layer separated by an absorbing layer. The reflective surfaces of the Fabry Perot cavity may be located at the interface between the absorbing layer and the high or low refractive index layers. In one or more embodiments, the Fabry Perot Cavity may reduce the transmission of ultraviolet light through the coating. Such embodiments may include alternating layers of mixed polyimide and metal oxide layers and polyimide layers, as described herein.

[0096] In one or more embodiments, the coating may comprise a continuous phase and a non-continuous phase. The non-continuous phase may comprise bodies or inclusions within the continuous phase. In one or more embodiments, the difference in refractive index between the one or more materials of the continuous phase and the one or more materials of the non-continuous phase may be at least 0.5. For example, the difference in refractive index between the one or more materials of the continuous phase and the one or more materials of the non-continuous phase may be at least 0.5, at least 0.6, at least 0.7, at least 0.8, at least 0.9 or even at least 1.0. Without wishing to be bound by theory, the difference in refractive index between the continuous phase and non-continuous phase may lead to the reflection and scattering of light, which may include ultraviolet light. It is contemplated that the coating comprising a continuous phase and a non-continuous phase may be optimized for ultraviolet light reflection and scattering by adjusting the thickness of the coating, the size of the inclusions, the shape of the inclusions, and the distribution of the inclusions.

[0097] In one or more embodiments the one or more materials comprising the continuous phase may absorb at least 50% more ultraviolet light than visible light. For example, the oneAttorney Docket No. SP24-161 or more in one or more embodiments, the materials comprising the continuous phase may absorb at least 50%, at least 60%, at least 70%, at least 80%, or even at least 90% more ultraviolet light than visible light. In one or more embodiments, the continuous phase may comprise metal oxide. For example, the continuous phase may comprise TiCh. ZrCF. AI2O3, or combinations of these. In at least one embodiment, the continuous phase may comprise TiO2.

[0098] In one or more embodiments, the non-continuous phase may comprise one or more polymers or one or more inorganic particles. In one or more embodiments, the one or more polymers may comprise a polyimide. In one or more embodiments, the inorganic particles may be hollow.

[0099] In one or more further embodiments, the coating may comprise a TiCh continuous phase and polyimide inclusions in a non-continuous phase. FIG. 3 and FIG. 4 display a coating comprising polyimide inclusions in a continuous TiCF coating. In one or more embodiments, the irregular shapes of the polyimide inclusions and the difference in refractive index between the TiCF and the polyimide may aid in the reflection and scattering of light.

[0100] In one or more embodiments, the coating may comprise cavities, where the refractive index of the coating is at least 0.5 greater than the refractive index of the cavity. For example the refractive index of the coating may be at least 0.5, at least 0.6, at least 0.7, at least 0.8, at least 0.9 or even at least 1.0 greater than the refractive index of the cavity.

[0101] In one or more embodiments, the cavities may be formed by the decomposition or volatilization of a sacrificial material. As described herein, a “sacrificial material” is a material that decomposes or volatilizes during a thermal curing process. In one or more embodiments, sacrificial material may be introduced into the coating during the coating process and before a thermal curing process. Subsequently, the sacrificial material may create cavities in the coating during athermal curing process. In one or more embodiments, the difference between the refractive index of the coating and the refractive index of the cavity may result in light reflection and scattering. In one or more embodiments, the differenceAttorney Docket No. SP24-161 between the refractive index of the coating and the cavity may result in the reflection and scattering of ultraviolet light.

[0102] In one or more embodiments, the coating may comprise a layer having a thickness of at least 10 nm, wherein the layer comprises a material that absorbs at least 50% more ultraviolet light than visible light. For example, the layer may have a thickness of at least 10 nm, at least, 20 nm, at least 30 nm, at least 40 nm, at least 50 nm, at least 60 nm, at least 70 nm, at least 80 nm, at least 90 nm, at least 100 nm, at least 200 nm, at least 300 nm, at least 400 nm, at least 500 nm, at least 600 nm, at least 700 nm, at least 800 nm, at least 900 nm, or even at least 1000 nm. In further examples, the layer may comprise a material that absorbs at least 50%, at least 60%, at least 70%, at least 80%, or even at least 90% more ultraviolet light than visible light.

[0103] In one or more embodiments, the layer may comprise a metal oxide. For example, the layer may comprise one or more of TiCh. ZrC , and AI2O3. In one or more embodiments, the coating may comprise TiCh. In one or more embodiments, the TiCh may have a high absorbance of ultraviolet light with a wavelength between 250 and 400 nm as shown in the UV-Vis absorption spectrum for TiCh displayed in FIG. 5. In one or more embodiments, the thickness of the TiCh layer may be adjusted to increase the ultraviolet light absorbing properties of the coating. For example, in one or more embodiments, as the thickness of the TiCh layer increases, the absorbance of ultraviolet light by the TiCh layer may increase.

[0104] In one or more embodiments, the coating may comprise one or more compounds that absorb ultraviolet light and dissipate at least 50% of the energy absorbed from ultraviolet light as heat. For example, the compounds may absorb ultraviolet light and dissipate at least 50%, at least 60%, at least 70%, at least 80%, at least 90%, or even at least 99% of the energy absorbed from ultraviolet light as heat. In one or more embodiments, these compounds may include benzophenones, benzotriazoles, triazines, and oxalanilides.

[0105] In one or more embodiments, the coating may comprise one or more photochromic compounds. As described herein, “photochromic compounds” may be compounds that have an absorption spectrum that changes when the photochromic compound is exposed toAttorney Docket No. SP24-161 ultraviolet light. In one or more embodiments, the absorption spectrum of the photochromic compound may change such that the absorption of ultraviolet light increases when the photochromic compound is exposed to ultraviolet light. In one or more embodiments, the photochromic compound that has been exposed to ultraviolet light and has undergone an adsorption spectrum change may revert to its original absorption spectrum when the exposure to ultraviolet light ceases. An example photochromic compound is made by Nemoto Lumi Materials Company, Kanagawa Japan Y S-A4 and is a red pigmented dye that may be white in color, absorb UV light, and transmit red light.

[0106] In one or more embodiments, the photochromic compounds may comprise a first absorption spectrum and a second absorption spectrum where the photochromic compounds exhibit the second absorption spectrum when exposed to ultraviolet light of a sufficient intensity for a sufficient length of time. In one or more embodiments, the intensity of ultraviolet light and length of time necessary for the photochromic compound to exhibit a second absorption spectrum may vary depending on the photochromic compound being used. In one or more embodiments, sunlight may provide ultraviolet light of sufficient intensity for the photochromic compound to exhibit a second absorption spectrum. In one or more embodiments, the necessary length of time may be 0.5 seconds to 20 minutes. For example, the necessary length of time may be from 0.5 seconds to 20 minutes, from 0.5 seconds to 15 minutes, from 0.5 seconds to 10 minutes, from 0.5 seconds to 9 minutes, from 0.5 seconds to 8 minutes, from 0.5 seconds to 7 minutes, from 0.5 seconds to 6 minutes, from 0.5 seconds to 5 minutes, from 0.5 seconds to 4 minutes, from 0.5 seconds to 3 minutes, from 0.5 seconds to 2 minutes, from 0.5 seconds to 1 minute, from 0.5 seconds to 50 seconds, from 0.5 seconds to 40 seconds, from 0.5 seconds to 30 seconds, from 0.5 seconds to 20, seconds, from 0.5 seconds to 10 seconds, from 0.5 seconds to 5 seconds, or even from 0.5 seconds to 1 second. In one or more embodiments, the second absorption spectrum may absorb at least 5% more ultraviolet light than the first absorption spectrum. For example, the second absorption spectrum may absorb at least 5%, at least 10%, at least 20%, at least 30%, at least 40%, at least 50%, at least 60%, at least 70%, at least 80%, at least 90%, or even at least 99% more ultraviolet light than the first absorption spectrum.Attorney Docket No. SP24-161

[0107] In one or more embodiments, the molecules of the photochromic compounds may undergo a conformational change when the photochromic material is exposed to ultraviolet light. This conformational change may cause a change in the absorption spectrum of the photochromic compounds.

[0108] In one or more embodiments, the photochromic compound may absorb more visible light when exposed to ultraviolet light. This may cause the coating to darken or develop color when exposed to ultraviolet light. In one or more embodiments, this coloring is reversible and disappears when the coating is no longer exposed to ultraviolet light.

[0109] In one or more embodiments, photochromic compounds may be organic compounds or inorganic compounds. For example, the one or more photochromic compounds may be hexaarylbiimidaxoles, diarylethenes, photochromic quinones, or zinc compounds. Additionally, other suitable photochromic compounds known in the art may be used in the coating, including photochromic compounds suitable for use in transition lenses for eyeglasses.

[0110] In one or more embodiments, the window portion 128 of the partially coated glass container 100 may possess a clarity sufficient to allow for the automated visual inspection of the contents of a vial. The window portion 128 may also possess a clarity sufficient to allow for the manual inspection of the contents of the container, such as manual inspection by a medical professional or end point user. This may be particularly important for the detection of glass delamination within containers, or the efficacy or sterility of the contents of the partially coated glass container 100.

[0111] In one or more embodiments, the one or more layers comprising the coating may be applied to a vial surface by spray coating. In one or more embodiments, spray coating may be a suitable method for depositing a polymer, a polyimide, PMDA-ODA, a high refractive index layer, a low refractive index layer, an absorbing layer, a metal oxide layer, a titania layer, an alumina layer, a zirconia layer, a silica layer, a layer comprising a continuous phase and a non-continuous phase, a continuous layer comprising a sacrificial material, a layer comprising a photochromic compound and combinations of these. In one or moreAttorney Docket No. SP24-161 embodiments spray coating may be suitable for depositing a layer at least 10 nm thick. For example, spray coating may be suitable for depositing a layer at least 10 nm, at least, 20 nm, at least 30 nm, at least 40 nm, at least 50 nm, at least 60 nm, at least 70 nm, at least 80 nm, at least 90 nm, at least 100 nm, at least 200 nm, at least 300 nm, at least 400 nm, at least 500 nm, at least 600 nm, at least 700 nm, at least 800 nm, at least 900 nm, or even at least 1000 nm thick.

[0112] Referring again to FIGS. 1 and 2, the coating 120 may be applied in a single deposition step where the coating 120 comprises a single layer. Deposition may be by a submersion process, or alternatively, the coating 120 may be applied by a spray or other suitable means, and optionally dried. A description of suitable deposition methods for the coatings 120 described herein may be found in U.S. Patent No. 9,763,852 entitled “Glass Articles with Low-Friction Coatings,” which is incorporated by reference in its entirety herein. In additional embodiments, multiple depositions may be utilized. For example, multiple coating precursor depositions may be performed and then cured, or curing may follow each deposition step, such that a second coating of precursor is applied onto a cured layer.

[0113] In one or more embodiments, the coating 120 applied to the glass body 102 may have a thickness of less than or equal to about 100 pm, less than or equal to about 10 pm, less than or equal to about 8 pm, less than or equal to about 6 pm, less than or equal to about 4 pm, less than or equal to about 3 pm, less than or equal to about 2 pm, or even less than or equal to about 1 pm. In some embodiments, the thickness of the coating 120 may be less than or equal to about 800 nm, less than or equal to about 600 nm, less than or equal to about 400 nm 300 nm, less than or equal to about 200 nm, or even less than or equal to about 100 nm thick. In other embodiments, the coating 120 may be less than about 90 nm thick, less than about 80 nm thick, less than about 70 nm thick, less than about 60 nm thick, less than about 50 nm, or even less than about 25 nm thick. In embodiments, the coating 120 may have a thickness of at least about 10 nm, at least about 15 nm, at least about 20 nm, at least about 25 nm, at least about 30 nm, at least about 35 nm, at least about 40 nm, or even at least about 45 nm. Exemplary embodiments may have a thickness of from about 20 nm to about 50 nm,Attorney Docket No. SP24-161 from about 25 nm to about 45 nm, or from about 30 nm to about 40 nm. Without being bound by theory, it is believed that relatively thin coatings (i.e., less than 20 nm) may not adequately protect the glass, resulting in checking on the glass surface during vial-to-vial contact. In addition such relatively thin coatings may not survive a depyrogenation process. On the other hand, relatively thick coatings (z.e., greater than 50 nm) may be more easily damaged and wear tracks in the coating may appear from vial-on-vial contacting. It should be noted that in the case of the relatively thick coatings, the wear tracks are believed to be deformations in the coating, and not in the glass. As described herein, wear tracks are visible tracks caused by abrasion on a coating, leaving a track or scuff. In some embodiments, wear tracks may signify glass checking and / or relatively high coefficient of friction (e.g., 0.7 or greater).

[0114] In some embodiments, the coating 120 may not be of uniform thickness over the entirety of the glass body 102. For example, the partially coated glass container 100 may have a thicker coating 120 in some areas, due to the process of contacting the glass body 102 with one or more coating solutions that form the coating 120. In some embodiments, the coating 120 may have a non-uniform thickness. For example, the coating thickness may be varied over different regions of a coated glass container 100, which may promote protection in a selected region.

[0115] Embodiments of this disclosure include methods of spray coating a glass container to form the at least one coated portion and the portion, as well as manufacturing apparatuses used in coating the glass container. Specifically, embodiments includes methods and tools to selectively spray glass pharmaceutical vials with a coating (e.g., a UV-light-blocking coating) that minimizes the presence of droplets of the coating in the uncoated window portion. The window portion is intended to provide end-users with the ability to view the interior or contents of the pharmaceutical packaging despite the presence of a UV-blocking coating on one or more portions of the vial. For example, pharmaceutical packing often has a table applied to the exterior of the glass container. For UV-sensitive pharmaceutical contents, portions of the pharmaceutical not covered by the label may have a UV-blocking coating, while portions under the label can remain free of the UV-blocking coating so that, when the label was detached or peeled back to reveal the uncoated window portion, the contents of theAttorney Docket No. SP24-161 pharmaceutical package can be viewed through the window portion, which presents minimal loss of visible light through the uncoated, transparent window portion. However, application of the coating to the glass container requires either removing the coating from the window portion or, more preferably, masking the window portion to prevent application of the coating to the area of the window portion.

[0116] Applying an adhesive mask to the window portion of glass container for dip coating the remainder of the glass container is one option. However, such a process can lead to undesirable results, including the coating formulation bleeding through the tape, causing large stria defects in the uncoated window portion. Furthermore, removing the adhesive mask prior to curing created artifacts in the transition region between the coated portion and the window portion, resulting in an area with less light absorption and an undesirable appearance. In addition, dip coating processes present scalability challenges, requiring significant investments to overcome issues such as vial gripping during tape removal and automated removal of excess formulation.

[0117] To achieve a droplet-free window portion with a desirable appearance, including no striations and smooth transitions between the at least one coating portion and the window portion, a contactless and stationary mask was developed to effectively block the coating precursor during the airless spray process. The implementation of this mask results in a smoother transition between the coated portion and window portion on the glass container. Furthermore, the mask’s shape can minimize the presence of droplets within the window portion, enhancing overall quality and visual clarity.

[0118] According to embodiments, the contactless shadow mask is used in conjunction with an adhesive mask adhered to the glass container. Advantages of this approach include further mitigating formulation bleeding issues and further eliminating stria defects in the window portion.

[0119] Examples of embodiments of the contactless shadow mask method and apparatus can be found below in the Examples section.Attorney Docket No. SP24-161

[0120] The glass containers of the pharmaceutical packages, to which the coating 120 may be applied, may be formed from a variety of different glass compositions. The specific composition of the glass article may be selected according to the specific application such that the glass has a desired set of physical properties. According to one or more embodiments, the glass may be a composition which is known to exhibit chemical durability and low thermal expansion, such as alkali borosilicate glasses. According to another embodiment, may be formed from a Type I, Class B glass according to ASTM Standard E438-92.

[0121] The glass containers may be formed from a glass composition which has a coefficient of thermal expansion in the range from about 25xlO'7 / °C to 80xl0'7 / °C. For example, in some embodiments described herein, the glass body 102 is formed from alkali aluminosilicate glass compositions which are amenable to strengthening by ion exchange. Such compositions generally include a combination of SiCh, AI2O3, at least one alkaline earth oxide, and one or more alkali oxides, such as Na2O and / or K2O. In some of these embodiments, the glass composition may be free from boron and compounds containing boron. In some other embodiments the glass compositions may further comprise minor amounts of one or more additional oxides such as, for example, SnCh. ZrCh, ZnO, TiCh. AS2O3, or the like. These components may be added as fining agents and / or to further enhance the chemical durability of the glass composition. In another embodiment, the glass surface may comprise a metal oxide coating comprising SnC , ZrCF. ZnO, TiO2, AS2O3, or the like.

[0122] In some embodiments described herein, the glass body 102 is strengthened such as by ion-exchange strengthening, herein referred to as “ion-exchanged glass”. For example, the glass body 102 may have a compressive stress of greater than or equal to about 300 MPa or even greater than or equal to about 350 MPa. In some embodiments, the compressive stress may be in a range from about 300 MPa to about 900 MPa. However, it should be understood that, in some embodiments, the compressive stress in the glass may be less than 300 MPa or greater than 900 MPa. In some embodiments, the glass body 102 may have a depth of layer greater than or equal to 20 pm. In some of these embodiments, the depth of layer may beAttorney Docket No. SP24-161 greater than 50 gm or even greater than or equal to 75 gm. In still other embodiments, the depth of the layer may be up to or greater than 100 pm. The ion-exchange strengthening may be performed in a molten salt bath maintained at temperatures from about 350 °C to about 500 °C. To achieve the desired compressive stress, the glass container (uncoated) may be immersed in the salt bath for less than about 30 hours or even less than about 20 hours. For example, in one embodiment the glass container is immersed in a 100% KNO3 salt bath at 450 °C for about 8 hours.

[0123] In one particularly exemplary embodiment, the glass body 102 may be formed from an ion exchangeable glass composition described in pending U.S. Patent Application Serial No. 13 / 660,894 fded October 25, 2012, and entitled “Glass Compositions with Improved Chemical and Mechanical Durability” assigned to Coming, Incorporated.

[0124] However, it should be understood that the partially coated glass containers 100 described herein may be formed from other glass compositions including, without limitation, ion-exchangeable glass compositions and non-ion exchangeable glass compositions. For example, in some embodiments the glass container may be formed from Type IB glass compositions such as, for example, Schott Type IB borosilicate glass.

[0125] In some embodiments described herein, the glass article may be formed from a glass composition which meets the criteria for pharmaceutical glasses described by regulatory agencies such as the USP (United States Pharmacopoeia), the EP (European Pharmacopeia), and the JP (Japanese Pharmacopeia) based on their hydrolytic resistance. Per USP 660 and EP 7, borosilicate glasses meet the Type I criteria and are routinely used for parenteral packaging. Examples of borosilicate glass include, but are not limited to, Coming® Pyrex® 7740, 7800 and Wheaton 180, 200, and 400, Schott Duran, Schott Fiolax, KIMAX® N-51A, Gerrescheimer GX-51 Flint and others. Soda-lime glass meets the Type III criteria and is acceptable in packaging of dry powders which are subsequently dissolved to make solutions or buffers. Type III glasses are also suitable for packaging liquid formulations that prove to be insensitive to alkali. Examples of Type III soda lime glass include Wheaton 800 and 900. De-alkalized soda-lime glasses have higher levels of sodium hydroxide and calcium oxide and meet the Type II criteria. These glasses are less resistant to leaching than Type I glassesAttorney Docket No. SP24-161 but more resistant than Type III glasses. Type II glasses can be used for products that remain below a pH of 7 fortheir shelflife. Examples include ammonium sulfate treated soda lime glasses. These pharmaceutical glasses have varied chemical compositions and have a coefficient of linear thermal expansion (CTE) in the range of 20-85 x 10 "7 / °C.

[0126] When the coated glass articles described herein are glass containers, the glass body 102 of the partially coated glass containers 100 may take on a variety of different forms. For example, the glass bodies described herein may be used to form partially coated glass containers 100 such as vials, ampoules, cartridges, syringe bodies and / or any other glass container for storing pharmaceutical compositions. Moreover, the ability to chemically strengthen the glass containers prior to coating can be utilized to further improve the mechanical durability of the glass containers. Accordingly, it should be understood that, in at least one embodiment, the glass containers may be ion exchange strengthened prior to application of the coating. Alternatively, other strengthening methods such as heat tempering, flame polishing, and laminating, as described in U.S. Patent No. 7,201,965, could be used to strengthen the glass before coating.

[0127] Various properties of the coated glass containers (i.e., coefficient of friction, horizontal compression strength, 4-point bend strength) may be measured when the coated glass containers are in an as-coated condition (i.e., following application of the coating without any additional treatments other than curing if applicable) or following one or more processing treatments, such as those similar or identical to treatments performed on a pharmaceutical filling line, including, without limitation, washing, lyophilization, depyrogenation, autoclaving, or the like.

[0128] Depyrogenation is a process wherein pyrogens are removed from a substance. Depyrogenation of glass articles, such as pharmaceutical packages, can be performed by a thermal treatment applied to a sample in which the sample is heated to an elevated temperature for a period of time. For example, depyrogenation may include heating a glass container to a temperature of between about 250 °C and about 380 °C for a time period from about 30 seconds to about 72 hours, including, without limitation, 20 minutes, 30 minutes 40 minutes, 1 hour, 2 hours, 4 hours, 8 hours, 12 hours, 24 hours, 48 hours, and 72 hours.Attorney Docket No. SP24-161Following the thermal treatment, the glass container is cooled to room temperature. One conventional depyrogenation condition commonly employed in the pharmaceutical industry is thermal treatment at a temperature of about 250 °C for about 30 minutes. However, it is contemplated that the time of thermal treatment may be reduced if higher temperatures are utilized. The coated glass containers, as described herein, may be exposed to elevated temperatures for a period of time. The elevated temperatures and time periods of heating described herein may or may not be sufficient to depyrogenate a glass container. However, it should be understood that some of the temperatures and times of heating described herein are sufficient to depyrogenate a coated glass container, such as the coated glass containers described herein. For example, as described herein, the coated glass containers may be exposed to temperatures of about 250 °C, about 260 °C about 270 °C, about 280 °C, about 290 °C, about 300 °C, about 310 °C, about 320 °C, about 330 °C, about 340 °C, about 350 °C, about 360 °C, about 370 °C, about 380 °C, about 390 °C, or about 400 °C, for a period of time of 30 minutes. It is recognized that depyrogenation processes may have times other than 30 minutes, and 30 minutes is used throughout this disclosure with a depyrogenation temperature for comparative purposes such as, for example, coefficient of friction testing following exposure to a defined depyrogenation condition.

[0129] As used herein, lyophilization conditions (i.e., freeze drying) refer to a process in which a sample is filled with a liquid that contains protein and then frozen at low temperatures, such as -100 °C, followed by water sublimation for a time such as 20 hours at temperatures such as -15 °C under vacuum.

[0130] As used herein, autoclave conditions refer to steam purging a sample for a time period such as 10 minutes at 100 °C, followed by a 20-minute dwelling period wherein the sample is exposed to a 121 °C environment, followed by 30 minutes of heat treatment at 121 °C.

[0131] The coefficient of friction (p) of the portion of the coated glass container with the coating may have a lower coefficient of friction than a surface of an uncoated glass container formed from a same glass composition. A coefficient of friction (p) is a quantitative measurement of the friction between two surfaces and is a function of the mechanical andAttorney Docket No. SP24-161 chemical properties of the first and second surfaces, including surface roughness, as well as environmental conditions such as, but not limited to, temperature and humidity. As used herein, a coefficient of friction measurement for coated glass container 100 is reported as the coefficient of friction between the outer surface of a first glass container (having an outer diameter of between about 16.00 mm and about 17.00 mm) and the outer surface of second glass container which is substantially identical to the first glass container, wherein the first and second glass containers have the same body and the same coating composition (when applied) and have been exposed to the same environments prior to fabrication, during fabrication, and after fabrication. Unless otherwise denoted herein, the coefficient of friction refers to the maximum coefficient of friction measured with a normal load of 30 N measured on a vial -on-vial testing jig. However, it should be understood that a coated glass container which exhibits a maximum coefficient of friction at a specific applied load will also exhibit the same or better (i.e., lower) maximum coefficient of friction at a lesser load. For example, if a coated glass container exhibits a maximum coefficient of friction of 0.5 or lower under an applied load of 50 N, the coated glass container will also exhibit a maximum coefficient of friction of 0.5 or lower under an applied load of 25 N. To measure a maximum coefficient of friction, local maxima at or near the beginning of the test are excluded, as such maxima at or near the beginning of the test represent static coefficient of friction. As described in the embodiments herein, the coefficient of friction was measured where the speed of the containers relative to one another was about 0.67 mm / s.

[0132] In the embodiments described herein, the coefficient of friction of the glass containers (both coated and uncoated) is measured with a vial-on-vial testing jig. The same apparatus may also be used to measure the frictive force between two glass containers positioned in the jig. The vial-on-vial testing jig comprises a first clamp and a second clamp arranged in a cross configuration (i.e., perpendicular to one another). The first clamp comprises a first securing arm attached to a first base. The first securing arm attaches to the first glass container and holds the first glass container stationary relative to the first clamp. Similarly, the second clamp comprises a second securing arm attached to a second base. The second securing arm attaches to the second glass container and holds it stationary relative to the second clamp. The first glass container is positioned on the first clamp and the secondAttorney Docket No. SP24-161 glass container is positioned of the second clamp such that the long axis of the first glass container and the long axis of the second glass container are positioned at about a 90° angle relative to one another and on a horizontal plane defined by the x-y axis.

[0133] A first glass container is positioned in contact with the second glass container at a contact point. A normal force is applied in a direction orthogonal to the horizontal plane defined by the x-y axis. The normal force may be applied by a static weight or other force applied to the second clamp upon a stationary first clamp. For example, a weight may be positioned on the second base and the first base may be placed on a stable surface, thus inducing a measurable force between the first glass container and the second glass container at the contact point. Alternatively, the force may be applied with a mechanical apparatus, such as a UMT (universal mechanical tester) machine.

[0134] The first clamp or second clamp may be moved relative to the other in a direction which is at a 45° angle with the long axis of the first glass container and the second glass container. For example, the first clamp may be held stationary and the second clamp may be moved such that the second glass container moves across the first glass container in the direction of the x-axis. A similar setup is described by R. L. De Rosa et al., in “Scratch Resistant Polyimide Coatings for Alumino Silicate Glass surfaces” in The Journal of Adhesion, 78: 113-127, 2002. To measure the coefficient of friction, the force required to move the second clamp and the normal force applied to first and second glass containers are measured with load cells and the coefficient of friction is calculated as the quotient of the frictive force and the normal force. The jig is operated in an environment of 25 °C and 50% relative humidity.

[0135] In the embodiments described herein, the portion of the coated glass container with the coating has a coefficient of friction of less than or equal to about 0.7 relative to a like- coated glass container, as determined vial-on-vial testing. In other embodiments, the coefficient of friction may be less than or equal to about 0.6, or even less than or equal to about 0.5. In some embodiments, the portion of the coated glass container with the coating has a coefficient of friction of less than or equal to about 0.4 or even less than or equal to about 0.3. Coated glass containers with coefficients of friction less than or equal to about 0.7Attorney Docket No. SP24-161 generally exhibit improved resistance to frictive damage and, as a result, have improved mechanical properties. For example, conventional glass containers (without a coating) may have a coefficient of friction of greater than 0.7.

[0136] In some embodiments described herein, the coefficient of friction of the portion of the coated glass container with the coating is at least 20% less than a coefficient of friction of a surface of an uncoated glass container formed from a same glass composition. For example, the coefficient of friction of the portion of the coated glass container with the coating may be at least 20% less, at least 25% less, at least 30% less, at least 40% less, or even at least 50% less than a coefficient of friction of a surface of an uncoated glass container formed from a same glass composition.

[0137] In some embodiments, the portion of the coated glass container with the coating may have a coefficient of friction of less than or equal to about 0.7 after exposure to a temperature of about 250 °C, about 260 °C, about 270 °C, about 280 °C, about 290 °C, about 300 °C, about 310 °C, about 320 °C, about 330 °C, about 340 °C, about 350 °C, about 360 °C, about 370 °C, about 380 °C, about 390 °C, or about 400 °C, for a period of time of 30 minutes. In other embodiments, the portion of the coated glass container with the coating may have a coefficient of friction of less than or equal to about 0.7, (i.e., less than or equal to about 0.6, less than or equal to about 0.5, less than or equal to about 0.4, or even less than or equal to about 0.3) after exposure to a temperature of about 250 °C, about 260 °C, about 270 °C, about 280 °C, about 290 °C, about 300 °C, about 310 °C, about 320 °C, about 330 °C, about 340 °C, about 350 °C, about 360 °C, about 370 °C, about 380 °C, about 390 °C, or about 400 °C, for a period of time of 30 minutes. In some embodiments, the coefficient of friction of the portion of the coated glass container with the coating may not increase by more than about 30% after exposure to a temperature of about 250 °C (or about 260°C) for 30 minutes. In other embodiments, coefficient of friction of the portion of the coated glass container with the coating may not increase by more than about 30% (i.e., about 25%, about 20%, about 15%, or even about 10%) after exposure to a temperature of about 250 °C, about 260 °C, about 270 °C, about 280 °C, about 290 °C, about 300 °C, about 310 °C, about 320 °C, about 330 °C, about 340 °C, about 350 °C, about 360 °C, about 370 °C, about 380 °C,Attorney Docket No. SP24-161 about 390 °C, or about 400 °C, for a period of time of 30 minutes. In other embodiments, coefficient of friction of the portion of the coated glass container with the coating may not increase by more than about 0.5 (i.e., about 0.45, about 0.4, about 0.35, about 0.3, about 0.25, about 0.2, about 0.15, about 0.1, or even about 0.05) after exposure to a temperature of about 250°C, about 260 °C, about 270 °C, about 280 °C, about 290 °C, about 300 °C, about 310 °C, about 320 °C, about 330 °C, about 340 °C, about 350 °C, about 360 °C, about 370 °C, about 380 °C, about 390 °C, or about 400 °C, for a period of time of 30 minutes. In some embodiments, the coefficient of friction of the portion of the coated glass container with the coating may not increase at all after exposure to a temperature of about 250 °C, about 260 °C, about 270 °C, about 280 °C, about 290 °C, about 300 °C, about 310 °C, about 320 °C, about 330 °C, about 340 °C, about 350 °C, about 360 °C, about 370 °C, about 380 °C, about 390 °C, or about 400 °C, for a period of time of 30 minutes.

[0138] In some embodiments, the portion of the coated glass container with the coating may have a coefficient of friction of less than or equal to about 0.7 after being submerged in a water bath at a temperature of about 70 °C for 10 minutes. In other embodiments, the portion of the coated glass container with the coating may have a coefficient of friction of less than or equal to about 0.7, (i.e., less than or equal to about 0.6, less than or equal to about 0.5, less than or equal to about 0.4, or even less than or equal to about 0.3) after being submerged in a water bath at a temperature of about 70 °C for 5 minutes, 10 minutes, 20 minutes, 30 minutes, 40 minutes, 50 minutes, or even 1 hour. In some embodiments, the coefficient of friction of the portion of the coated glass container with the coating may not increase by more than about 30% after being submerged in a water bath at a temperature of about 70 °C for 10 minutes. In other embodiments, coefficient of friction of the portion of the coated glass container with the coating may not increase by more than about 30% (i.e., about 25%, about 20%, about 15%, or event about 10%) after being submerged in a water bath at a temperature of about 70 °C for 5 minutes, 10 minutes, 20 minutes, 30 minutes, 40 minutes, 50 minutes, or even 1 hour. In some embodiments, the coefficient of friction of the portion of the coated glass container with the coating may not increase at all after being submerged in a water bath at a temperature of about 70 °C for 5 minutes, 10 minutes, 20 minutes, 30 minutes, 40 minutes, 50 minutes, or even 1 hour.Attorney Docket No. SP24-161

[0139] In some embodiments, the portion of the coated glass container with the coating may have a coefficient of friction of less than or equal to about 0.7 after exposure to lyophilization conditions. In other embodiments, the portion of the coated glass container with the coating may have a coefficient of friction of less than or equal to about 0.7, (i.e., less than or equal to about 0.6, less than or equal to about 0.5, less than or equal to about 0.4, or even less than or equal to about 0.3) after exposure to lyophilization conditions. In some embodiments, the coefficient of friction of the portion of the coated glass container with the coating may not increase by more than about 30% after exposure to lyophilization conditions. In other embodiments, coefficient of friction of the portion of the coated glass container with the coating may not increase by more than about 30% (i.e., about 25%, about 20%, about 15%, or event about 10%) after exposure to lyophilization conditions. In some embodiments, the coefficient of friction of the portion of the coated glass container with the coating may not increase at all after exposure to lyophilization conditions.

[0140] In some embodiments, the portion of the coated glass container with the coating may have a coefficient of friction of less than or equal to about 0.7 after exposure to autoclave conditions. In other embodiments, the portion of the coated glass container with the coating may have a coefficient of friction of less than or equal to about 0.7, (i.e., less than or equal to about 0.6, less than or equal to about 0.5, less than or equal to about 0.4, or even less than or equal to about 0.3) after exposure to autoclave conditions. In some embodiments, the coefficient of friction of the portion of the coated glass container with the coating may not increase by more than about 30% after exposure to autoclave conditions. In other embodiments, coefficient of friction of the portion of the coated glass container with the coating may not increase by more than about 30% (i.e., about 25%, about 20%, about 15%, or event about 10%) after exposure to autoclave conditions. In some embodiments, the coefficient of friction of the portion of the coated glass container with the coating may not increase at all after exposure to autoclave conditions.

[0141] The coated glass containers described herein have a horizontal compression strength. The horizontal compression strength, as described herein, is measured by positioning the coated glass container 100 horizontally between two parallel platens whichAttorney Docket No. SP24-161 are oriented in parallel to the long axis of the glass container. A mechanical load is then applied to the coated glass container 100 with the platens in the direction perpendicular to the long axis of the glass container. Prior to being placed in the platens, the glass containers are wrapped in 2 inch tape, and the overhang is cut off or folded around the bottom of the container. The container is then positioned within an index card that is stapled around the specimen. The load rate for vial compression is 0.5 in / min, meaning that the platens move towards each other at a rate of 0.5 in / min. The horizontal compression strength is measured at 25°C ± 2°C and 50% ± 5% relative humidity. It is desirable, in some embodiments, to perform the horizontal compression test within 1 hour (and not more than 24 hours) following depyrogenation to simulate pharmaceutical fdling line conditions. The horizontal compression strength is a measurement of load at failure, and measurement of the horizontal compression strength can be given as a failure probability at a selected normal compression load. As used herein, failure occurs when the glass container ruptures under a horizontal compression in least 50% of samples. Thus, the horizontal compression is provided for a group of samples. In some embodiments, a coated glass container may have a horizontal compression strength at least 10%, 20%, or 30% greater than an uncoated vial.

[0142] In some embodiments, the partially coated glass container 100 may have a coating 120 that is capable of receiving an adhesive label. That is, the partially coated glass container 100 may receive an adhesive label on the coated surface of the coated portion 126 such that the adhesive label is securely attached. However, the ability of attachment of an adhesive label is not a requirement for all embodiments of the coated glass containers 100 described herein.Examples

[0143] The various embodiments of glass containers with coatings will be further clarified by the following examples. The examples are illustrative in nature, and should not be understood to limit the subject matter of the present disclosure. It should be understood that, in all examples, uncoated vials were colorless to the naked eye unless specified otherwise. Also, all light transmission is reported as passing through a single wall of the glass vial,Attorney Docket No. SP24-161 which can be measured by cutting the vial in half or by calculating the light transmission measure through two walls of a vial.

[0144] Example 1 - Polyimide Single Layer

[0145] An ion exchanged alkali aluminosilicate glass vial (16.75 mm outer diameter) was coated with PMDA-ODA Kapton polyimide coating. The vial was colorless to the eye prior to coating. Spectral transmission data is provided in FIG. 6 for the uncoated vial (301), the coated vial (302), and a comparative amber vial common in the marketplace (303). Spectral data was gathered for light passing through two wall of the vial. As is shown in FIG. 6, the coated vial provided adequate UV protection, equivalent to that of an amber vial in many UV wavelengths. Less than 10% transmittance was observed across the entire UV spectrum.

[0146] Example 2 - Mixed Metal Oxide / Polyimide Layer

[0147] A coating was applied to an aluminosilicate glass. The coating was prepared by mixing Tyzor BTP (a commercially available n-butyl polytitanate) with Nexolve CPI (a commercially available polyimide) in a weight ratio of 95 / 5 Tyzor BTP / CP 1. The coating mixture contained 3.35 wt.% solids (i.e., the Tyzor BTP and CPI) with the remainder solvent. Additional solids ratios of 7 / 93 and 10 / 90 were also tested. The solvent consisted of n- propylacetate and Dowanol PMA in a 89 / 7 ratio by weight. The coating was sprayed onto numerous vials in an airless spray. The coating was then cured at 350°C in a convection oven.

[0148] The coating thickness was varied by controlling the spray time and percent solids utilized. Table 1 shows coating spraying time and the resulting average thickness, as well as number of samples tested. All samples had a coefficient of friction of less than 0.5.

[0149] The light transmission was tested for each of Samples A-K of Table 1. The light transmission is depicted in FIG. 12, and Table 1 provides the figure numbers corresponding to each sample. Light transmission was determined from a single vial measured at three locations and averaged.Attorney Docket No. SP24-161Table 1

[0150] As can be seen from the data of Table 1 and FIG. 12, the UV protection was relatively good regardless of coating thickness. Applying additional coating did not provide substantially more UV protection. It is believed that increasing the thickness does not make a linearly increasing attenuation because of thin fdm light interference effects due to fdm thickness and high reflectivity.

[0151] Example 3 - Mixed Polyimide / Metal Oxide Underlayer and Polyimide Overlayer

[0152] A coating that contained Tyzor BTP (a commercially available n-butyl polytitanate) with Nexolve CPI (a commercially available polyimide) in a weight ratio of 95 / 5 Tyzor BTP / CP1 was applied at a solids wt.% of 3.35, similar to that of Example 2. The coating was applied and cured as disclosed in Example 2. Then, over the initial layer, of layer of only CPI was applied, where the solids wt.% of CPI in solvent was varied, and spray time and / or dipping was controlled to attain desired thickness of the outer coating layer. The outer coating layer of CPI was cured as well at 350°C.Attorney Docket No. SP24-161

[0153] The light transmission was tested for each of Samples L-0 of Table 2. Sample P is indicative of bare glass (uncoated). The light transmission is depicted in FIG. 13, and Table 2 provides the figure numbers corresponding to each sample. Light transmission was determined from a single vial measured at three locations and averaged. All samples had a coefficient of friction of less than 0.5 and were colorless to the naked eye.Table 2

[0154] As is seen through the changes in thicknesses of the polyimide overlayer, increasing the thickness does not make a linearly increasing attenuation because of thin film light interference effects due to film thickness and high reflectivity.

[0155] Example 4 - Aminopropyl Silsesquioxane Underlayer and Polyimide OverlayerAttorney Docket No. SP24-161

[0156] A coated pharmaceutical package was prepared as follow. The vials to be coated were washed with de-ionized water, blown dry with nitrogen, and finally cleaned by exposure to oxygen plasma for 15 seconds prior to coating. Then, the vials were dip-coated as follow. First, a tie layer of aminopropyl silsequioxane (SSQ) was applied on the glass surface by dip coating using a 4 wt.% SSQ. The 4 wt.% SSQ solution was prepared from a 22-25% stock SSQ solution, available from ABCR under the reference AB127715, CAS No: 29159-37-3, and diluted with a mix of methanol and water.

[0157] The SSQ tie layer was deposited by dip coating at a 200 mm / min withdrawing speed and was cured at 150°C for 8 min. The 150 nm thick SSQ tie layer obtained was overcoated with a PMDA-ODA polyimide layer. The polyimide layer was prepared from PMDA-ODA polyamic acid in NMP / Xylene, CAS 25038-81-7, available from Sigma Aldrich under the reference 575771, was convert into its triethylamine (TEA) salt form and dissolved in a methanol. The PMDA-ODA -TEA solution concentration was 3.6 % by weight. Coatings exhibiting different thicknesses were prepared by dip coating at a withdrawing speed ranging from 50, 200, 400,700, 1000 mm / min. The PMDA-ODA coating was cured at 360°C for 15 min to allow the imidization reaction to occur. The coated vials were visibly yellow in color, and increased in yellow intensity with thickness.

[0158] The thickness of the coating was determined using a ZYGO interferometers to precisely measure the total coating thickness. Thicknesses ranging from 0.5 to about 2.2 pm was achieved. The measured thicknesses are given in FIG. 7, which also depicts light transmission for each sample at 400 nm. The light transmission was determined using a spectrophotometer, Agilent, Cary 5000 equipped with an integrating sphere, DRA2500, passing through two walls of the vial. FIG. 9 shows transmission spectra for the sample dipped at 400 mm / min (372) versus an uncoated vial (370).

[0159] The vials were then longitudinally cut in two halves using a diamond and the transmission was measured through a single wall for the SSQ / PMDA-ODA coating prepared at 400 mm / min dip coating speed. FIG. 8 depicts the transmissions curves obtained for the uncoated and coated vials. Below, Table 3 shows the dipping speeds utilized for polyimide layer deposition (i.e., the PMDA-ODA outer layer). One sample was not coated as aAttorney Docket No. SP24-161 reference, and another sample was coated with SSQ but not PMDA-ODA as another reference.Table 3

[0160] As is shown in FIG. 8, in several samples a great deal of or all of UVB and UVC radiation is blocked, whereas the transmittance in the visible range remains relatively good.

[0161] The coated pharmaceutical packages were depyrogenated at 260°C for 30 min and subjected to the scratch test under 30N load using a vial-on-vial testing jig. The coefficient of friction refers here to the coefficient of friction measured with a normal load of 30 N measured on a vial-on-vial testing jig. COF testing was conducted on samples as cured, i.e, after 360 °C for 15 hours thermal treatment, and following a heat treatment of 260 °C for 0.25 hours. After being tested under 30 N load, the surface was free of scratches, and wear was not visible. The average coefficient of friction (COF) was measured as 0.22.

[0162] Example 5 - Colloidal Silver Incorporated Into Polyimide CoatingAttorney Docket No. SP24-161

[0163] This example illustrates the preparation of glass package having an UV-blocking polyimide film made by in-situ reduction of silver ions. A silver salt particle suspension was prepared by dissolving 0.9 g AgNCh in 11 mb ethanol followed by addition of 7.68 g of hits -(Trimethoxysilyl) propyl] ethylenediamine, CAS number 1760-24-3 available from Sigma Aldrich under the ref 104884. The suspension was aged at room temperature for 24 hours. Then a coating composition was made by adding 10 g of the supernatant of this silver particle suspension into 20 g of a polyamic acid solution consisting in 1.46 g of PMDA-ODA polyamic acid in its form of triethylamine salt, 13 g of methanol, 4.2 g of NMP and 1 g of Xylene. The solution was homogenized by manual mixing. Then clean glass vials were dip- coated using the solution of polyamic / silver mixture described above. Thereafter, the coated vials were dried using hot air supplied by an air gun set at about 500°C, followed by a heat treatment of 350 °C for 0.25 hours.

[0164] The coated vials exhibited a brown color which is darker than the PMDA-ODA coating free of silver. The vials were subjected to the scratch test under 30 N load using a vial-on-vial testing jig. A micrograph of the surface of the coating after being tested under 30 N load showed that the surface was free of scratches, wear was not visible, and the average coefficient of friction (COF) was 0.22, which is shown in FIG. 10 where the y-axis represents COF and the x-axis represents time or distance of scratch testing.

[0165] Example 6 - Silver Incorporated Into Another Polyimide Coating

[0166] The protocol of example 5 was repeated except that the PMDA-ODA polyamic acid was replaced by the 6FDA-4-BDAF polyimide commercially available from NEXOLVE as LARC-CP1. The solution was prepared by adding 10 ml N-(2-Aminoethyl-3- aminopropyljtrimethoxysilane-AgNOs-EtOH mixture, similar as prepared in Example 5 but using a different reducing agent, into 20 ml 3.5 wt.% LARC-CP1 polyimde dissolved in n- propyl acetate. After dip coating the wet layer was dried under a gentle hot air flow set at about 500°C during for 2-3 minutes after which amber brown color appeared. The coating was then post-cured at 360°C for 15 minutes. An amber vial was obtained.

[0167] Example 7 - Copper and Iron Incorporated into Tie-Layer UndercoatAttorney Docket No. SP24-161

[0168] This example illustrates the preparation of a glass package having a UV-blocking tie layer made by in-situ reduction of iron and copper ions and having an overcoat made of clear LARC-CP 1. polyimide coating (6FDA-4-BDAF polyimide commercially available from NEXOLVE as ref LARC-CP 1).

[0169] A suspension containing both copper and iron salt particles was prepared by dissolving 0. 126 g copper nitrate and 0.91 iron nitrate in 13 g proof ethanol, followed by the addition of 8.75 g N- [3 -(Trimethoxy silyl) propyl] ethylenediamine. The solution was aged for 24 hours. Then cleaned glass vials were dip-coated at a withdrawing speed of 300 mm / min to coat this solution onto the glass. Thereafter, the coated vials were dried using hot air supplied by an air gun set at about 600°C for 3 minutes. The COF of the tie layer alone was found to be about 0.52 with a good glass protection against scratching. In order to reduce the COF even more the vials on which the UV-blocking tie layer was applied were subsequently dip-coated using a 3.5 wt.% clear polyimide solution prepared from LARC-CP 1 dissolved in n-propyl acetate. The resulting coating was made of an amber tie layer with a polyimide overlayer and exhibited a COF of about 0.27. One vial was longitudinally cut in two halves using a diamond and the transmission was measured through a single wall. The transmission for the uncoated vials (380) and coated glass vials (382) are shown in FIG. 11, respectively.

[0170] Example 8 -Iron Incorporated into Mixed Titanium / Polyimide Coating

[0171] A solution of 3 g of titanium butoxide (5593-70-4, Sigma Aldrich) and 2 g of Iron (III) methacrylate (CAS# 94275-77-1, Gelest) in 95g of n-propylacetate was prepared, which was stored at room temperature for 3 days. The solution formed a colored complex that had a very yellowish amber color. To the solution was added 0.25 g of Nexolve colorless polyimide CPI and was mixed unti. dissolved (2 hours). A vial was dipped into the solution and removed at 240 mm / min. The vial was then blotted dry and place on mesh rack, following by curing at 350°C.Attorney Docket No. SP24-161

[0172] In some samples, an additional outer layer of CP 1 polyimde was applied and cured over the first layer. The CPI polyimide was applied in a 3 wt.% solids solution at a dip speed of 240 mm / min, and cured at 350°C.

[0173] Example 9

[0174] A coating was applied identical to that of Example 8, but instead of Iron (III) methacrylate, 1.8 g of Iron (III) 2,4 Pentanedionate (CAS#14024-18-l, Gelest) was added.

[0175] Example 10

[0176] The following is an example of the contactless shadow mask, according to embodiments of this disclosure.

[0177] Initially, formation of the window portion was attempted by applying the coating directly over a 19 mm thick piece of adhesive tape. However, as shown in Fig. 14, this approach presented challenges such as coating bleeding, stria defects 1002, and thinning at the transition area 1004. As a result, alternative apparatuses and methods were necessary to overcome these issues.

[0178] Next, a mask was placed over the intended window portion of the vial and within 2 mm from the vials to prevent any contact with the vials but also to avoid major deviation from the target window size. This approach also improved coating uniformity in the transition area between the coated portions and window portion of the vial. However, spraying the vials without any masking tape revealed the presence of coating droplets in the window portion. These droplets reduced light transmission, could be mistaken for particulate matter during automatic inspection, and could accumulate at the edges of the tape, exacerbating coating bleeding. This was attributed to the formation of small droplets due to turbulent flow in the spray process that hit the mask and bounced into the window portion.

[0179] To address the issue of droplets in the window portion, as shown in Figure 15, a shadow mask 1100 with side shields 1102 were incorporated onto the contactless mask. The shadow mask 1100 retained the window portion shield 1104, but the side shields 1102 were placed on either side of the window portion shield 1104. Figure 15 shows an inverted 10RAttorney Docket No. SP24-161 vial 1106 held in a chuck 1108. The chuck 1108 can be rotated so that the spray nozzle can coat the vial around its circumference. The shadow mask 1100 includes the window portion shield 1104 and side shields 1102. These shields effectively prevented smaller droplets originating from the peripheral region of the spray cone from falling onto the unmasked area. This occurs due to the smaller droplets comparatively lower surface area, which makes them more susceptible to drag and subsequently results in lower velocity. Consequently, the droplets originating from the edges of the spray cone were more likely to deviate from the straight line along the liquid direction and subsequently collide with the window portion. The side shields yielded significant improvements in the coating process. Notably, they greatly reduced the density of droplets present in the window portion, thereby mitigating issues related to coating accumulation near the edges of the tape and minimizing the occurrence of stria defects. As a result, the utilization of the shielded, contactless mask made a substantial contribution in ensuring a higher quality and visually appealing final product.

[0180] Images of the coated vials using the contactless shadow masks both with side shields and without side shields were analyzed using Image J software. The purpose of this analysis was to assess the coverage of droplets on the window portion, as depicted in Fig. 16. As shown in Fig. 16, using the side shielded shadow mask resulted in a significant reduction in the density of defects. This can be attributed to the effective blocking of smaller droplets originating from the peripheral region of the spray cone. No adhesive contact tape was used for the vials in Fig. 16.

[0181] Fig. 17 shows the percentage of area in the window portion covered with droplets. In Fig. 17, a clear distinction can be observed when analyzing the percentage of area covered with droplets in the window portion. The left column represents vials coated using a regular shadow mask without side shields, while the right column represents vials coated using a shadow mask with side shields. The results illustrate different combinations of spray pressure, coating layers, and spray time. It is evident that the inclusion of side shields had a significant impact in reducing the coverage of droplets on the uncoated area. This finding highlights the effectiveness of the side shields in improving the overall quality of the coating process.Attorney Docket No. SP24-161

[0182] In Fig. 18A, a brightfield image of a 1 OR vial coated using the side-shielded mask, in conjunction with a masking tape, is displayed. It is evident that there are no instances of coating bleeding, and the threshold image of the uncoated area reveals minimal presence of droplets, as shown in the closeup view of the threshold transition region in Fig. 18B. This observation is further supported by the UV-Visible spectrum, shown in Fig. 18C, which demonstrates that the spectrum of the uncoated window completely overlaps with that of an uncoated vial. These findings confirm the effectiveness of the side shielded mask and masking tape in achieving the desired outcome of minimal droplet coverage and maintaining the integrity of the uncoated region.

[0183] It will be apparent to those skilled in the art that various modifications and variations can be made to the embodiments described herein without departing from the spirit and scope of the claimed subject matter. Thus it is intended that the specification cover the modifications and variations of the various embodiments described herein provided such modification and variations come within the scope of the appended claims and their equivalents.

Claims

1. Attorney Docket No. SP24-161CLAIMSWhat is claimed is:

1. A coated pharmaceutical package comprising: a glass container comprising a first surface and a second surface opposite the first surface, wherein the first surface is an outer surface of the glass container, and wherein the glass container in an uncoated state has an average light transmittance in the UVB and UVC spectrum of at least 50% through a single wall of the coated package; a coated portion on at least one portion of the first surface, the coated portion comprising a coating positioned over the at least one portion of the first surface of the glass container, wherein the coated pharmaceutical package has an average light transmittance in the coated portion in the UVC spectrum of less than 50% through a single wall of the coated package, and wherein the coated pharmaceutical package has a light transmittance of less than 20% at all wavelengths from 400 nm to 450 nm; and a window portion on the first surface, wherein the window portion does not comprise the coating on the first surface within the window portion, and wherein the coated pharmaceutical package has an average light transmittance in the window portion that is greater than the average light transmittance in the coated portion.

2. The coated pharmaceutical package of claim 1, wherein the window portion is visibly colorless.

3. The coated pharmaceutical package of claim 1, wherein the coated pharmaceutical package meets that standard of USP <660> Spectral Transmission for Colored Glass Containers.

4. The coated pharmaceutical package of any one of claims 1-3, wherein the glass container in the uncoated state is visibly colorless.Attorney Docket No. SP24-1615. The coated pharmaceutical package of any preceding claim, wherein the coating comprises a polymer and one or more of copper, silver, or iron.

6. The coated pharmaceutical package of claim 5, wherein the polymer is a polyimide.

7. The coated pharmaceutical package of claim 5, wherein the coating further comprises a reducing agent.

8. The coated pharmaceutical package of claim 7, wherein the reducing agent is a silane.

9. The coated pharmaceutical package of any preceding claim, wherein the coating comprises a coupling agent layer comprising: a silane and one or more of silver, copper, or iron; and a polymer layer comprising polyimide.

10. The coated pharmaceutical package of any preceding claim, wherein the coating comprises a mixed layer comprising: a poly imide; one or more of titania, alumina, or zirconia; and one or more of silver, copper, or iron.

11. A spray coating apparatus used in applying a coating material onto a portion of an outer surface of a glass object, comprising: a coating material source comprising a coating material; a spray nozzle assembly comprising a spray nozzle fluidly connected to the coating material source, the spray nozzle arranged and configured to direct the coating material in a first direction toward the glass object; and a shadow mask disposed in the first direction from the spray nozzle and configured to be disposed between the glass object and the spray nozzle, wherein the shadow mask comprises a masking material at a first masking position disposed in a line of sight between a window portion of the glass object and the spray nozzle,Attorney Docket No. SP24-161 the masking material being configured to block the coating material from depositing on the window portion of the glass object, and wherein the shadow mask further comprises a masking material disposed at lateral masking positions on lateral sides of the first masking position to prevent overspray of the coating material from being redirected around the shadow mask and onto the first portion of the glass object.

12. The spray coating apparatus of claim 11, wherein the shadow mask further comprises at least one opening allowing a line of sight between at least one coating portion of the glass object and the spray nozzle, the at least one opening being configured to allow the coating material to be deposited on the at least one coating portion of the glass object.

13. The spray coating apparatus of claim 11 or claim 12, wherein the lateral masking positions are not disposed in a line of sight between the spray nozzle and the glass object.

14. The spray coating apparatus of any one of claims 11-13, wherein the shadow mask is configured to be spaced apart from the glass object.

15. The spray coating apparatus of any one of claims 11-14, wherein the masking material comprises a flat metal surface.

16. The spray coating apparatus of any one of claims 11-15, further comprising an adhesive mask configured to be adhered to the glass object in the window portion.

Images